Emergent BioSolutions Inc. (EBS) › Net IncomeEmergent BioSolutions Inc. (EBS) — Net IncomeAnnual figures by period end, from SEC filings.2009-12-31: $31.14M2010-12-31: $51.70M2011-12-31: $23.02M2012-12-31: $23.52M2013-12-31: $31.14M2014-12-31: $36.74M2015-12-31: $62.87M2016-12-31: $51.80M2017-12-31: $82.60M2018-12-31: $62.70M2019-12-31: $54.50M2020-12-31: $305.80M2021-12-31: $219.50M2022-12-31: -$211.60M2023-12-31: -$760.50M2024-12-31: -$190.60M2025-12-31: $52.60M$52.60M2009-12-31Net Income (USD)2025-12-31Period endedNet IncomeChange YoYSource filing2025-12-31$52.60M—2026-02-27From 2025-01-012024-12-31-$190.60M—2026-02-27From 2024-01-012023-12-31-$760.50M—2026-02-27From 2023-01-012022-12-31-$211.60M-196.4%2025-03-04From 2022-01-012021-12-31$219.50M-28.2%2024-03-08From 2021-01-012020-12-31$305.80M+461.1%2023-12-11From 2020-01-012019-12-31$54.50M-13.1%2022-02-25From 2019-01-012018-12-31$62.70M-24.1%2021-02-19From 2018-01-012017-12-31$82.60M+59.5%2020-02-25From 2017-01-012016-12-31$51.80M-17.6%2019-02-22From 2016-01-012015-12-31$62.87M+71.1%2018-02-23From 2015-01-012014-12-31$36.74M+18.0%2017-02-28From 2014-01-012013-12-31$31.14M+32.4%2016-02-29From 2013-01-012012-12-31$23.52M+2.2%2015-03-09From 2012-01-012011-12-31$23.02M-55.5%2014-03-10From 2011-01-012010-12-31$51.70M+66.0%2013-03-08From 2010-01-012009-12-31$31.14M—2012-03-09From 2009-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)